Erypro Safe Erythropoietin Alfa Injection 40000IU

Name: Erypro Safe Erythropoietin Alfa Injection 40000IU
Brand: K T Agencies
Price: 10890.0 INR
Availability: InStock

Price 10890.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Erypro Safe Erythropoietin Alfa Injection 40000IU Specification

Indication
HIV infection, Anemia associated with chronic renal failure

Dosage Form
Injection

Salt Composition
Recombinant Human Erythropoietin Alfa

Enzyme Types
Glycoprotein hormone

Feature
Sterile, safe, recombinant protein

Ingredients
Erythropoietin Alfa

Application
Treats anemia due to chronic kidney disease, HIV treatment

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Enzymatic Activity
Stimulates erythropoiesis

Storage Instructions
Store at 2C-8C. Do not freeze.

Shelf Life
3 years

Preservative Free
Yes

Prescription Required
Yes

Strength
40000 IU/ml

Packaging Type
Pre-filled syringe

Single Use Only
Yes

Route of Administration
Intravenous or subcutaneous

Erypro Safe Erythropoietin Alfa Injection 40000IU Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
100 Pieces Per Month

Delivery Time
7 Days

About Erypro Safe Erythropoietin Alfa Injection 40000IU

Erypro Safe Erythropoietin Alfa Injection 40000IU is a distinguished, top-rated solution for anemia management, particularly in HIV infection and chronic renal failure. Delivered via a superior pre-filled syringe, this single-use, preservative-free injection features recombinant human erythropoietin alfa, ensuring safety and reliability. Promoting majestic health outcomes, its sterile, odorless, clear solution boasts excellent enzymatic activity, stimulating erythropoiesis. Prescribed by doctors and packaged for export from India, Erypro Safe is your trusted choice-redeem the benefits of advanced therapy and superior patient care. Store between 2C-8C. Shelf life: 3 years.

Material Features and Application Surface

Erypro Safe Erythropoietin Alfa Injection is renowned for its sterile and preservative-free formulation, offering a superior clear, colorless solution of recombinant human erythropoietin alfa. Designed strictly for single use, it is administered intravenously or subcutaneously for therapeutic effect. The injection's enzymatic action directly targets blood circulation, effectively stimulating erythropoiesis to treat anemia linked to chronic kidney disease and HIV infection. Its distinguished safety profile and consistent efficacy set it apart in clinical practice.

Domestic Market Presence and Supply Details

Erypro Safe maintains a significant market value across India, supplied at the lowest price for healthcare providers. The product is distributed in secure, pre-filled syringes, ensuring patient safety and ease of administration. With robust supply ability and reliable packaging specifications, it guarantees an outlay-efficient solution for both small clinics and large hospitals. Its prominence in the Indian domestic market further underscores its superior therapeutic standing among anemia treatments.

FAQ's of Erypro Safe Erythropoietin Alfa Injection 40000IU:

Q: How is Erypro Safe Erythropoietin Alfa Injection 40000IU administered?

A: It is administered either intravenously or subcutaneously, as directed by a healthcare professional, ensuring precise dosage and optimal therapeutic effect.

Q: What conditions does Erypro Safe Erythropoietin Alfa Injection treat?

A: This injection is specifically indicated for the treatment of anemia associated with chronic kidney disease and HIV infection.

Q: When should Erypro Safe Erythropoietin Alfa Injection be used?

A: Erypro Safe should be used when prescribed by a medical professional, following confirmed diagnosis of anemia linked to chronic renal failure or HIV infection.

Q: Where should Erypro Safe Erythropoietin Alfa Injection be stored?

A: Store the injection in a refrigerator at 2C-8C. Do not freeze. Proper storage maintains its potency and ensures safety.

Q: What is the process for redeeming the benefits of Erypro Safe in clinical settings?

A: The product's superior recombinant protein formulation, combined with single-use, sterile packaging, makes it easy for clinicians to administer and achieve distinguished treatment outcomes.

Q: What are the primary benefits of using Erypro Safe Erythropoietin Alfa Injection?

A: Key benefits include safe, effective anemia management, superior sterile delivery, and proven efficacy, offering patients reliable improvement in their red blood cell count.

Tell us about your requirement